For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241219:nRSS6646Qa&default-theme=true
RNS Number : 6646Q Spire Healthcare Group PLC 19 December 2024
19 December 2024
Spire Healthcare Group plc
Transaction in own shares
Spire Healthcare Group plc (the "Company") announces that, in accordance with
the terms of its share buyback programme announced on 31 October 2024 (the
"Share Buyback Programme") and the authority granted by its shareholders at
the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased
the following number of its ordinary shares of 1 pence each ("Shares") on the
London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):
Date of purchase: 18 December 2024
Number of Shares purchased: 50,000
Highest price paid per Share (GBp): 228.50
Lowest price paid per Share (GBp): 226.00
Volume weighted average price paid per Share (GBp): 227.2598
Broker: Deutsche Numis
Trading venue: London Stock Exchange
The purchased Shares will be cancelled.
Following the purchase of these Shares, the remaining number of Shares in
issue will be 402,851,824. The Company does not hold any Shares in treasury.
Therefore, the total number of voting rights in the Company is 402,851,824.
This figure may be used by shareholders as the denominator for the calculation
by which they can determine if they are required to notify their interest in,
or a change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms
part of domestic law of the United Kingdom by virtue of the European Union
(Withdrawal) Act 2018, the table below contains detailed information of the
individual trades made by Deutsche Numis as part of the Share Buyback
Programme:
Date of purchase Number of ordinary shares purchased Transaction price Time of transaction (UK Time) Transaction reference number Trading venue
(GBp share)
18 December 2024 575 226.50 08:45:43 00072863102TRLO0 XLON
18 December 2024 840 226.50 08:45:43 00072863101TRLO0 XLON
18 December 2024 200 226.50 08:45:43 00072863100TRLO0 XLON
18 December 2024 2037 226.00 08:48:48 00072863130TRLO0 XLON
18 December 2024 2245 227.00 09:17:15 00072863790TRLO0 XLON
18 December 2024 605 227.00 09:17:15 00072863789TRLO0 XLON
18 December 2024 1467 227.00 09:17:15 00072863788TRLO0 XLON
18 December 2024 803 227.00 10:04:12 00072864878TRLO0 XLON
18 December 2024 870 227.00 10:04:12 00072864877TRLO0 XLON
18 December 2024 711 227.00 10:04:12 00072864876TRLO0 XLON
18 December 2024 215 227.00 10:19:30 00072865242TRLO0 XLON
18 December 2024 2125 227.00 10:19:30 00072865241TRLO0 XLON
18 December 2024 2021 226.50 11:21:55 00072866919TRLO0 XLON
18 December 2024 2383 226.50 13:01:01 00072869371TRLO0 XLON
18 December 2024 894 226.50 13:01:01 00072869370TRLO0 XLON
18 December 2024 1316 226.50 13:01:01 00072869369TRLO0 XLON
18 December 2024 186 226.50 13:41:44 00072870144TRLO0 XLON
18 December 2024 1100 226.50 13:41:44 00072870143TRLO0 XLON
18 December 2024 952 226.50 13:41:44 00072870142TRLO0 XLON
18 December 2024 2275 226.50 14:29:15 00072871298TRLO0 XLON
18 December 2024 2428 226.50 14:29:15 00072871297TRLO0 XLON
18 December 2024 284 227.50 14:54:33 00072872518TRLO0 XLON
18 December 2024 651 227.50 15:03:33 00072872989TRLO0 XLON
18 December 2024 19 227.50 15:03:33 00072872988TRLO0 XLON
18 December 2024 660 227.50 15:03:33 00072872987TRLO0 XLON
18 December 2024 200 227.50 15:03:33 00072872986TRLO0 XLON
18 December 2024 45 227.50 15:03:33 00072872985TRLO0 XLON
18 December 2024 873 227.50 15:25:32 00072873836TRLO0 XLON
18 December 2024 2217 227.50 15:25:32 00072873835TRLO0 XLON
18 December 2024 1154 227.50 15:25:32 00072873834TRLO0 XLON
18 December 2024 79 228.00 15:34:15 00072874103TRLO0 XLON
18 December 2024 930 228.50 15:35:15 00072874122TRLO0 XLON
18 December 2024 4915 228.50 15:35:15 00072874121TRLO0 XLON
18 December 2024 2179 228.00 15:36:49 00072874141TRLO0 XLON
18 December 2024 234 227.50 15:36:54 00072874142TRLO0 XLON
18 December 2024 1785 227.50 15:37:28 00072874175TRLO0 XLON
18 December 2024 189 228.00 16:07:15 00072875106TRLO0 XLON
18 December 2024 157 228.00 16:07:15 00072875105TRLO0 XLON
18 December 2024 2765 228.00 16:07:25 00072875108TRLO0 XLON
18 December 2024 332 228.00 16:07:25 00072875107TRLO0 XLON
18 December 2024 123 228.00 16:09:25 00072875223TRLO0 XLON
18 December 2024 511 228.00 16:09:25 00072875222TRLO0 XLON
18 December 2024 75 228.00 16:09:25 00072875221TRLO0 XLON
18 December 2024 1000 228.00 16:09:25 00072875220TRLO0 XLON
18 December 2024 286 228.00 16:09:25 00072875219TRLO0 XLON
18 December 2024 280 228.00 16:09:25 00072875218TRLO0 XLON
18 December 2024 468 228.00 16:09:25 00072875217TRLO0 XLON
18 December 2024 232 228.00 16:14:11 00072875454TRLO0 XLON
18 December 2024 9 228.00 16:20:11 00072875907TRLO0 XLON
18 December 2024 1100 228.00 16:20:11 00072875906TRLO0 XLON
This announcement will also be available on the Company's website at:
https://investors.spirehealthcare.com/news/regulatory-news/
Enquiries:
Spire Healthcare
Harbant Samra, CFO +44 (0)7881 672 365
Instinctif Partners
Julian Walker +44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare (http://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.
Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.
Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSKVLFFZLLLFBQ